Bleeding Events after Left Atrial Appendage Closure vs. Long Term Warfarin

Original Title: Bleeding Outcomes After Left Atrial Appendage Closure Compared With Long-Term Warfarin A Pooled, Patient-Level Analysis of the WATCHMAN Randomized Trial Experience. Reference: Matthew J. Price et al. J Am Coll Cardiol Intv. 2015. Online before print. The aim of this trial was to compare the relative risk of major bleeding after left atrial appendage closure<a href="https://solaci.org/en/2015/12/15/bleeding-events-after-left-atrial-appendage-closure-vs-long-term-warfarin/" title="Read more" >...</a>

Percutaneous Left Atrial Appendage Closure With the AMPLATZER : a valid alternative when anticoagulation is contraindicated

Original title: Percutaneous Left Atrial Appendage Closure With the AMPLATZER Cardiac Plug Device in Patients With Nonvalvular Atrial Fibrillation and Contraindication to Anticoagulation Therapy Reference: Marina Urena, et al. J Am Coll Cardiol 2013:62:96-102.   Anticoagulation is a good therapeutic strategy in nonvascular atrial fibrillation (AF). However, it is contraindicated in approximately 10% of patients, due to the<a href="https://solaci.org/en/2013/07/10/n-3424/" title="Read more" >...</a>

El cierre de orejuela es seguro con los nuevos dispositivos

Left Atrial Appendage Closure: As Effective in Men and Women?

Atrial fibrillation is the most prevalent arrhythmia and to prevent its potential complications, we should administer anticoagulants (OACs), either warfarin or the new direct oral anticoagulants (DOACs).  Even though these drugs have been shown effective, they still involve the risk of bleeding, especially gastrointestinal bleeding, which in turn leads to numerous hospitalizations. Left atrial appendage occlusion<a href="https://solaci.org/en/2023/08/18/left-atrial-appendage-closure-as-effective-in-men-and-women/" title="Read more" >...</a>

Do Men and Women Present the Same Evolution after Left Atrial Appendage Closure?

Atrial fibrillation is a very frequent type of arrythmia that affects both men and women alike. This entity is associated to higher mortality seeing as it favors stroke and hospitalization for cardiac failure.  At present, one of its valid treatment strategies is left atrial appendage closure, to reduce or prevent stroke and anticoagulation driven bleeding. <a href="https://solaci.org/en/2022/11/14/do-men-and-women-present-the-same-evolution-after-left-atrial-appendage-closure/" title="Read more" >...</a>

Leak periprotésico en cierre de orejuela, algo más que un valor para tener en cuenta

Peridevice Leak in Left Atrial Appendage Closure: more than one value to take into account

According to several registries, incomplete left atrial appendage (LAA) closure has been observed in up to 30% of cases after device implantation. The main cause of this complication is a mismatch between closure device and LAA ostium. The latter is elliptical in shape and varies in length, while the Watchman LAA closure device is round<a href="https://solaci.org/en/2022/07/29/peridevice-leak-in-left-atrial-appendage-closure-more-than-one-value-to-take-into-account/" title="Read more" >...</a>

Antithrombotic Therapy Post Percutaneous Left Atrial Appendage Closure

Percutaneous left atrial appendage closure (LAAO) with Watchman has FDA approval since March 2015, having shown, in the PROTECT-AF and PREVAIL studies, reduced risk of atrial fibrillation driven stroke, by excluding the left atrial appendage form systemic circulation.  Both studies used post procedure standardized protocols involving followup at 45 days and 6 months, imaging, and<a href="https://solaci.org/en/2022/07/15/antithrombotic-therapy-post-percutaneous-left-atrial-appendage-closure/" title="Read more" >...</a>

Left Atrial Appendage Closure: Effective to Reduce Risk of Stroke?

Original Title: Effectiveness of Left Atrial Appendage Exclusion Procedures to Reduce the Risk of Stroke: A Systematic Review of the Evidence. Reference: North Noelck et al. Circ Cardiovasc Qual Outcomes. July 2016. Published ahead of print.   Atrial fibrillation is an important cause of stroke. Oral anticoagulation reduces the risk of stroke but, on the<a href="https://solaci.org/en/2016/07/15/left-atrial-appendage-closure-effective-to-reduce-risk-of-stroke/" title="Read more" >...</a>

Left Atrial Appendage Closure: Still under fire? Mayra Guerrero, MD

Intracardiac Echocardiography to Guide Watchman Left Atrial Appendix Closure: Safe and Effective?

Left atrial appendix closure (LAAC) has become a frequent intervention for stroke prevention in patients with atrial fibrillation (AF) that make poor candidates for anticoagulation. However, it presents a complication with negative impact on procedural outcomes which is peridevice leak.  To reduce these complications, we use intra-procedural imaging, the transesophageal echocardiogram (TEE) being the most<a href="https://solaci.org/en/2023/03/02/intracardiac-echocardiography-to-guide-watchman-left-atrial-appendix-closure-safe-and-effective/" title="Read more" >...</a>

Miocardiopatía hipertrófica: análisis de una serie histórica

Do Short- and Long-Term Results of Left Atrium Appendage Closure Differ Between Men and Women?

Left atrium appendage closure (LAAC) is a major strategy to prevent stroke in patients with nonvalvular atrial fibrillation (AF). LAAC registries to date show that women present twice the risk for major events and higher rates of in-hospital complications and hospital re-hospitalization at 30 days when compared with men. However, long-term results according to sex are<a href="https://solaci.org/en/2022/11/14/do-short-and-long-term-results-of-left-atrium-appendage-closure-differ-between-men-and-women/" title="Read more" >...</a>